Ann: Additional MRI Medicare Licence Process, page-13

Andrew apologised for the delay in replying.  Reporting season has been very busy.

I had two issues, both centering around communication.

The first was the investment briefing.  I felt that other companies allowed small investors to listen in to these. 

AH said that starting from the next half, they would hold their own conference call, so we would be able to register for that.  This is very important to me, as you gain so much information from listening to the analysts and the answers given to them

My second issue was the lack of info on progress with China.

The institutions seem to have little interest in this viewing it as a blue sky potential, so I think that is why there wasn't a focus on it in the last report.  It certainly isn't dead, just proving slower and more difficult than perhaps first anticipated.  They are dealing with enormous state institutions in order to create a private market model.  I would imagine over the last year the macro environment in China has been particularly difficult. 

They have been working with Enlitic in the background with the financing and hope that will be successfully completed soon. They are also planning to have it deployed operationally in their network.

I felt all very positive.  I am happy with the progress in Australia and it is good to hear that the other bits  are still progressing.  China is such a wildcard - has enormous potential, but I can see ow it would be challenging to get it started, especially with Xi Jinping centralising control again.